Kevin Heyries, Ph.D.

Co-founder and Head of Business Development at AbCellera

Kevin Heyries, Ph.D. is the co-founder of Vancouver-based AbCellera and has led the development of AbCellera's antibody discovery platform that combines proprietary immunizations, microfluidics, high-throughput imaging, genomics, deep computation, artificial intelligence, and automation. Dr. Heyries has led antibody discovery programs and now leads the company’s business development and strategy activities.

Kevin_Heyries_AbCellera_BioTech_Pharma_Summit_2021_Profile

Title: Responding to the COVID-19 Pandemic with Antibodies, Small Molecules Drugs and Vaccines